TrialPloS one2015

A multicenter, randomized clinical trial comparing the three-weekly docetaxel regimen plus prednisone versus mitoxantone plus prednisone for Chinese patients with metastatic castration refractory prostate cancer.

Tie Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.